Liu, Mei <br/><br/>
Development of synthetic peptide-modified liposomes with LDL receptor targeting capacity and improved anticancer activity.  [electronic resource] 

 -  Molecular pharmaceutics  Jul 2014 
 - 2305-12 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1543-8392 
<br/><br/><label>Standard No.: </label>10.1021/mp400759d  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--chemistry<br/>Cell Line, Tumor<br/>Chemistry, Pharmaceutical--methods<br/>Daunorubicin--chemistry<br/>Drug Delivery Systems--methods<br/>Humans<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Liposomes--chemistry<br/>Maleimides--chemistry<br/>Mice<br/>Mice, Nude<br/>Peptides--chemistry<br/>Phosphatidylethanolamines--chemistry<br/>Polyethylene Glycols--chemistry<br/>Receptors, LDL--metabolism<br/>Tissue Distribution